PatchSiren cyber security CVE debrief
CVE-2026-105705 SourceCodester CVE debrief
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0, impacting the file Admin/add_drug.php with a cross-site scripting vulnerability. The attack can be carried out remotely. The exploit has been released to the public and may be used for attacks. This vulnerability affects the Drug Recommendation System 1.0, specifically within the Admin/add_drug.php file, allowing for cross-site scripting due to improper input validation. Defenders should assess exposure and verify security controls.
- Vendor
- SourceCodester
- Product
- Drug Recommendation System
- CVSS
- MEDIUM 5.3
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-10-06
- Original CVE updated
- 2026-10-08
- Advisory published
- 2026-10-06
- Advisory updated
- 2026-10-08
Who should care
Defenders responsible for the SourceCodester Drug Recommendation System 1.0 should assess exposure and verify the effectiveness of current security controls. This includes system administrators, security teams, and IT personnel who manage or interact with the Drug Recommendation System 1.0. These stakeholders need to prioritize verifying system exposure, evaluating current security measures, and implementing necessary mitigations to prevent exploitation.
Why it matters
Defenders should prioritize verifying exposure of the Drug Recommendation System 1.0 and assessing the effectiveness of current security controls due to the publicly available exploit and potential for remote attacks.
- Verify exposure of Drug Recommendation System 1.0
- Assess the effectiveness of current security controls
- Monitor for potential attacks using the exploit
Technical summary
The vulnerability is located in the Admin/add_drug.php file of the SourceCodester Drug Recommendation System 1.0. A manipulation can result in cross-site scripting. The attack is possible to be carried out remotely. The vulnerability exists due to insufficient input validation in the affected file, allowing an attacker to inject malicious scripts. Defenders should focus on validating input and ensuring proper security controls are in place to mitigate this vulnerability. The technical impact is cross-site scripting, which can lead to unauthorized actions within the application.
Defensive priority
Defenders should prioritize verifying exposure of the Drug Recommendation System 1.0 and assessing the effectiveness of current security controls.
Recommended defensive actions
- Verify exposure of Drug Recommendation System 1.0
- Assess the effectiveness of current security controls
- Monitor for potential attacks
- Apply vendor patches or updates if available
- Review system configurations for potential vulnerabilities
- Implement compensating controls for exposed systems
- Track and document remediation efforts
Evidence notes
The CVE record and source item provide details on the vulnerability, but limited information is available on affected versions and remediation. The exploit has been publicly released, increasing the urgency for defenders to verify exposure and assess security controls. Evidence is based on CVE and source item descriptions, with limitations noted in scope and remediation guidance.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-105705 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-105705
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-105705 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-105705
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
SourceCodester Drug Recommendation System add_drug.php cross site scripting
Unverified legacy reference
URL: https://raw.githubusercontent.com/CVEProject/cvelistV5/main/cves/2026/105xxx/CVE-2026-105705.json
cve_program_cvelist_v5
-
Source reference
Unverified legacy reference
URL: https://vuldb.com/vuln/413698
Supplemental source - vdb-entry
-
Source reference
Unverified legacy reference
URL: https://vuldb.com/vuln/413698/cti
Supplemental source - signature, permissions-required
-
Source reference
Unverified legacy reference
URL: https://vuldb.com/cve/CVE-2026-105705
Supplemental source - third-party-advisory
-
Source reference
Unverified legacy reference
URL: https://vuldb.com/submit/992054
Supplemental source - third-party-advisory
-
Source reference
Unverified legacy reference
URL: https://github.com/hackliu/Vulnerability-Reports/blob/master/Drug-Recommender-Web-App/VULN-05-XSS-Reflected-Stored.md
Supplemental source - exploit
-
Source reference
Unverified legacy reference
URL: https://www.sourcecodester.com/
Supplemental source - product
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.